The Market Reports

Index

1 Meningococcal Vaccination Market Overview
1.1 Product Overview and Scope of Meningococcal Vaccination
1.2 Meningococcal Vaccination Segment by Type
1.2.1 Global Meningococcal Vaccination Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Meningococcal Vaccination Segment by Application
1.3.1 Meningococcal Vaccination Sales Comparison by Application: (2021-2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Global Meningococcal Vaccination Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Vaccination Revenue 2016-2027
1.4.2 Global Meningococcal Vaccination Sales 2016-2027
1.4.3 Meningococcal Vaccination Market Size by Region: 2016 Versus 2021 Versus 2027

2 Meningococcal Vaccination Market Competition by Manufacturers
2.1 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2016-2021)
2.2 Global Meningococcal Vaccination Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Meningococcal Vaccination Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Meningococcal Vaccination Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Vaccination Market Competitive Situation and Trends
2.5.1 Meningococcal Vaccination Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Vaccination Players Market Share by Revenue
2.5.3 Global Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Meningococcal Vaccination Retrospective Market Scenario by Region
3.1 Global Meningococcal Vaccination Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Meningococcal Vaccination Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Meningococcal Vaccination Market Facts & Figures by Country
3.3.1 North America Meningococcal Vaccination Sales by Country
3.3.2 North America Meningococcal Vaccination Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meningococcal Vaccination Market Facts & Figures by Country
3.4.1 Europe Meningococcal Vaccination Sales by Country
3.4.2 Europe Meningococcal Vaccination Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meningococcal Vaccination Market Facts & Figures by Region
3.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
3.5.2 Asia Pacific Meningococcal Vaccination Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meningococcal Vaccination Market Facts & Figures by Country
3.6.1 Latin America Meningococcal Vaccination Sales by Country
3.6.2 Latin America Meningococcal Vaccination Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meningococcal Vaccination Market Facts & Figures by Country
3.7.1 Middle East and Africa Meningococcal Vaccination Sales by Country
3.7.2 Middle East and Africa Meningococcal Vaccination Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meningococcal Vaccination Historic Market Analysis by Type
4.1 Global Meningococcal Vaccination Sales Market Share by Type (2016-2021)
4.2 Global Meningococcal Vaccination Revenue Market Share by Type (2016-2021)
4.3 Global Meningococcal Vaccination Price by Type (2016-2021)

5 Global Meningococcal Vaccination Historic Market Analysis by Application
5.1 Global Meningococcal Vaccination Sales Market Share by Application (2016-2021)
5.2 Global Meningococcal Vaccination Revenue Market Share by Application (2016-2021)
5.3 Global Meningococcal Vaccination Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 JN-International Medical
6.2.1 JN-International Medical Corporation Information
6.2.2 JN-International Medical Description and Business Overview
6.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.2.4 JN-International Medical Product Portfolio
6.2.5 JN-International Medical Recent Developments/Updates
6.3 Novartis International
6.3.1 Novartis International Corporation Information
6.3.2 Novartis International Description and Business Overview
6.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis International Product Portfolio
6.3.5 Novartis International Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Baxter International
6.6.1 Baxter International Corporation Information
6.6.2 Baxter International Description and Business Overview
6.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Baxter International Product Portfolio
6.6.5 Baxter International Recent Developments/Updates
6.7 Biomed
6.6.1 Biomed Corporation Information
6.6.2 Biomed Description and Business Overview
6.6.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biomed Product Portfolio
6.7.5 Biomed Recent Developments/Updates
6.8 Serum Institute of India
6.8.1 Serum Institute of India Corporation Information
6.8.2 Serum Institute of India Description and Business Overview
6.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Serum Institute of India Product Portfolio
6.8.5 Serum Institute of India Recent Developments/Updates

7 Meningococcal Vaccination Manufacturing Cost Analysis
7.1 Meningococcal Vaccination Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Vaccination
7.4 Meningococcal Vaccination Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meningococcal Vaccination Distributors List
8.3 Meningococcal Vaccination Customers

9 Meningococcal Vaccination Market Dynamics
9.1 Meningococcal Vaccination Industry Trends
9.2 Meningococcal Vaccination Growth Drivers
9.3 Meningococcal Vaccination Market Challenges
9.4 Meningococcal Vaccination Market Restraints

10 Global Market Forecast
10.1 Meningococcal Vaccination Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Meningococcal Vaccination by Type (2022-2027)
10.2 Meningococcal Vaccination Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meningococcal Vaccination by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Meningococcal Vaccination by Application (2022-2027)
10.3 Meningococcal Vaccination Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meningococcal Vaccination by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Meningococcal Vaccination by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Meningococcal Vaccination Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Meningococcal Vaccination Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Meningococcal Vaccination Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Meningococcal Vaccination Covered in This Study
Table 5. Global Meningococcal Vaccination Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Meningococcal Vaccination Sales Share by Manufacturers (2016-2021)
Table 7. Global Meningococcal Vaccination Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Meningococcal Vaccination Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Meningococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Meningococcal Vaccination Manufacturing Sites and Area Served
Table 11. Manufacturers Meningococcal Vaccination Product Type
Table 12. Global Meningococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meningococcal Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccination as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Meningococcal Vaccination Sales by Region (2016-2021) & (K Units)
Table 16. Global Meningococcal Vaccination Sales Market Share by Region (2016-2021)
Table 17. Global Meningococcal Vaccination Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Meningococcal Vaccination Sales by Country (2016-2021) & (K Units)
Table 19. North America Meningococcal Vaccination Sales Market Share by Country (2016-2021)
Table 20. North America Meningococcal Vaccination Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Meningococcal Vaccination Revenue Market Share by Country (2016-2021)
Table 22. Europe Meningococcal Vaccination Sales by Country (2016-2021) & (K Units)
Table 23. Europe Meningococcal Vaccination Sales Market Share by Country (2016-2021)
Table 24. Europe Meningococcal Vaccination Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Meningococcal Vaccination Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Meningococcal Vaccination Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Meningococcal Vaccination Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Meningococcal Vaccination Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Meningococcal Vaccination Revenue Market Share by Region (2016-2021)
Table 30. Latin America Meningococcal Vaccination Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Meningococcal Vaccination Sales Market Share by Country (2016-2021)
Table 32. Latin America Meningococcal Vaccination Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Meningococcal Vaccination Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Meningococcal Vaccination Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Meningococcal Vaccination Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Meningococcal Vaccination Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Country (2016-2021)
Table 38. Global Meningococcal Vaccination Sales (K Units) by Type (2016-2021)
Table 39. Global Meningococcal Vaccination Sales Market Share by Type (2016-2021)
Table 40. Global Meningococcal Vaccination Revenue (Million US$) by Type (2016-2021)
Table 41. Global Meningococcal Vaccination Revenue Share by Type (2016-2021)
Table 42. Global Meningococcal Vaccination Price (US$/Unit) by Type (2016-2021)
Table 43. Global Meningococcal Vaccination Sales (K Units) by Application (2016-2021)
Table 44. Global Meningococcal Vaccination Sales Market Share by Application (2016-2021)
Table 45. Global Meningococcal Vaccination Revenue (Million US$) by Application (2016-2021)
Table 46. Global Meningococcal Vaccination Revenue Share by Application (2016-2021)
Table 47. Global Meningococcal Vaccination Price (US$/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Meningococcal Vaccination Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. JN-International Medical Corporation Information
Table 54. JN-International Medical Description and Business Overview
Table 55. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. JN-International Medical Meningococcal Vaccination Product
Table 57. JN-International Medical Recent Developments/Updates
Table 58. Novartis International Corporation Information
Table 59. Novartis International Description and Business Overview
Table 60. Novartis International Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Novartis International Meningococcal Vaccination Product
Table 62. Novartis International Recent Developments/Updates
Table 63. Sanofi Corporation Information
Table 64. Sanofi Description and Business Overview
Table 65. Sanofi Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sanofi Meningococcal Vaccination Product
Table 67. Sanofi Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Pfizer Meningococcal Vaccination Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Baxter International Corporation Information
Table 74. Baxter International Description and Business Overview
Table 75. Baxter International Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Baxter International Meningococcal Vaccination Product
Table 77. Baxter International Recent Developments/Updates
Table 78. Biomed Corporation Information
Table 79. Biomed Description and Business Overview
Table 80. Biomed Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Biomed Meningococcal Vaccination Product
Table 82. Biomed Recent Developments/Updates
Table 83. Serum Institute of India Corporation Information
Table 84. Serum Institute of India Description and Business Overview
Table 85. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Serum Institute of India Meningococcal Vaccination Product
Table 87. Serum Institute of India Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Meningococcal Vaccination Distributors List
Table 91. Meningococcal Vaccination Customers List
Table 92. Meningococcal Vaccination Market Trends
Table 93. Meningococcal Vaccination Growth Drivers
Table 94. Meningococcal Vaccination Market Restraints
Table 95. Global Meningococcal Vaccination Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Meningococcal Vaccination Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Meningococcal Vaccination Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Meningococcal Vaccination Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Meningococcal Vaccination Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Meningococcal Vaccination Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Meningococcal Vaccination Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Meningococcal Vaccination Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Meningococcal Vaccination Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Meningococcal Vaccination Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Meningococcal Vaccination Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Meningococcal Vaccination Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meningococcal Vaccination
Figure 2. Global Meningococcal Vaccination Market Share by Type in 2020 & 2027
Figure 3. Polysaccharide Product Picture
Figure 4. Conjugate Product Picture
Figure 5. Combination Product Picture
Figure 6. Global Meningococcal Vaccination Market Share by Application in 2020 & 2027
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others
Figure 11. Global Meningococcal Vaccination Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Meningococcal Vaccination Market Size 2016-2027 (US$ Million)
Figure 13. Global Meningococcal Vaccination Sales 2016-2027 (K Units)
Figure 14. Global Meningococcal Vaccination Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Meningococcal Vaccination Sales Share by Manufacturers in 2020
Figure 16. Global Meningococcal Vaccination Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Meningococcal Vaccination Players: Market Share by Revenue in 2020
Figure 18. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Meningococcal Vaccination Sales Market Share by Region (2016-2021)
Figure 20. Global Meningococcal Vaccination Sales Market Share by Region in 2020
Figure 21. Global Meningococcal Vaccination Revenue Market Share by Region (2016-2021)
Figure 22. Global Meningococcal Vaccination Revenue Market Share by Region in 2020
Figure 23. U.S. Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Meningococcal Vaccination Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Meningococcal Vaccination by Type (2016-2021)
Figure 48. Sales Market Share of Meningococcal Vaccination by Application (2016-2021)
Figure 49. Sales Market Share of Meningococcal Vaccination by Application in 2020
Figure 50. Revenue Share of Meningococcal Vaccination by Application (2016-2021)
Figure 51. Revenue Share of Meningococcal Vaccination by Application in 2020
Figure 52. Manufacturing Cost Structure of Meningococcal Vaccination
Figure 53. Manufacturing Process Analysis of Meningococcal Vaccination
Figure 54. Meningococcal Vaccination Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed